HER3/Akt/mTOR pathway is a key therapeutic target for the reduction of triple-negative breast cancer metastasis via the inhibition of CXCR4 expression

por Takeda, Tomoya, Tsubaki, Masanobu, Genno, Shuji, Tokunaga, Kenta, Tanaka, Remi, Nishida, Shozo
Publicado 2023